Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: A multicenter, randomized, controlled trial

Clinical Infectious Diseases

Volumn 44, Issue 8, 2007, Pages 1057-1064

  Lindeboom, Jerome A ^a,b   Kuijper, Ed J ^c   Van Coppenraet, Elisabeth S Bruijnesteijn ^c   Lindeboom, Robert ^a   Prins, Jan M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; RIFABUTIN; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ABNORMAL FECES; ADOLESCENT; ALLERGIC RASH; ALLERGIC REACTION; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EXCISION; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; INFANT; JAUNDICE; LYMPHADENECTOMY; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIOSIS; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; STAPHYLOCOCCUS INFECTION; TOOTH DISCOLORATION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING; WOUND INFECTION; NEWBORN; PRESCHOOL CHILD; TUBERCULOUS LYMPHADENITIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; HUMANS; INFANT; INFANT, NEWBORN; LYMPH NODE EXCISION; RIFABUTIN; TREATMENT OUTCOME; TUBERCULOSIS, LYMPH NODE;

EID: 33947525207     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/512675     Document Type: Article

References (28)

1. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995; 20:954-63.
2. Danielides V, Patrikakos G, Moerman M, Bonte K, Dhooge C, Vermeersch H. Diagnosis, management and surgical treatment of nontuberculous mycobacterial head and neck infection in children. ORL J Otorhinolaryngol Relat Spec 2002; 64:284-9.
3. Schaad UB, Votteler TP, McCracken GH Jr, Nelson JD. Management of atypical mycobacterial lymphadentis in childhood: a review based on 380 cases. J Pediatr 1979; 95:356-60.
4. Margileth AM, Chandra R, Altman RP. Chronic lymphadenopathy due to mycobacterial infection: clinical features, diagnosis, histopathology, and management. Am J Dis Child 1984; 138:917-22.
5. Rahal A, Abela A, Arcand PH, Quintal MC, Lebel MH, Tapiero BF. Nontuberculous mycobacterial adenitis of the head and neck in children: experience from a tertiary care pediatric center. Laryngoscope 2001; 111:1791-6.
6. Sigalet D, Lees G, Fanning A. Atypical tuberculosis in the pediatric patient: implications for the pediatric surgeon. J Pediatr Surg 1992; 27:1381-4.
7. Suskind DL, Handler SD, Tom LW, Postsie WP, Wetmore RF. Nontuberculous mycobacterial cervical adenitis. Clin Pediatr (Phil) 1997; 36:403-9.
8. Dautzenberg B, Piperno D, Diot P, Truffot-Pernot C, Chauvin JP. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France. Chest 1995; 107:1035-40.
9. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK, Centers for Disease Control and Prevention, National Institutes of Health, Infectious Diseases Society of America. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53:1-112.
10. Tessier MH, Amoric JC, Mechinaud F, Dubesset D, Litoux P, Stadler JF. Clarithromycin for atypical mycobacterial lymphadenitis in nonimmunocompromised children. Lancet 1994; 344:1778.
11. Green PA, von Reyn CF, Smith RP Jr. Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol. Pediatr Infect Dis J 1993; 12:615-7.
12. Berger C, Pfyffer GE, Nadal D. Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. J Pediatr 1996; 128:383-6.
13. Lindeboom JA, de Lange J, van den Akker HP. Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87:50-4.
14. Hazra R, Robson CD, Perez-Atayde AR, Husson RN. Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy. Clin Infect Dis 1999; 28:123-9.
15. Luong A, McClay JE, Jafri HS, Brown O. Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis. Laryngoscope 2005; 115:1746-51.
16. Bruijnesteijn van Coppenraet ES, Lindeboom JA, Prins JM, Peeters MF, Claas EC, Kuijper EJ. Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children. J Clin Microbiol 2004; 42:2644-50.
17. Bruijnesteijn van Coppenraet ES, Kuijper EJ , Lindeboom JA, Prins JM, Claas EC. Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis 2005; 11:62-8.
18. Bergmans AM, Groothedde JW, Schellekens JF, van Embden JD, Ossewaarde JM, Schoułs LM. Etiology of cat scratch disease: comparison of polymerase chain reaction detection of Bartonella (formerly Rochalimaea) and Afipia felis DNA with serology and skin tests. J Infect Dis 1995; 171:916-23.
19. Yen TL, Driscoll CL, Lalwani AK. Significance of House-Brackmann facial nerve grading global score in the setting of different facial nerve function. Otol Neurotol 2003; 24:118-22.
20. Zhang X, Fei Z, Chen YJ, et al. Facial nerve function after excision of large acoustic neuromas via the suboccipital retrosigmoid approach. J Clin Neurosci 2005; 12:405-8.
21. Tunkel DE. Surgery for cervicofacial nontuberculous mycobacterial adenitis in children: an update. Arch Otolaryngol Head Neck Surg 1999; 125:1109-13.
22. Mandell DL, Wald ER, Michaels MG, Dohar JE. Management of nontuberculous mycobacterial cervical lymphadenitis. Arch Otolaryngol Head Neck Surg 2003; 129:341-4.
23. Panesar J, Higgins K, Daya H, Forte V, Allen U. Nontuberculous mycobacterial cervical adenitis: a ten-year retrospective review. Laryngoscope 2003; 113:149-54.
24. Maltezou HC, Spyridis P, Kafetzis DA. Nontuberculous mycobacterial lymphadenitis in children. Pediatr Infect Dis J 1999; 18:968-70.
25. Lindeboom JA, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R, Kuijper EJ. Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum. Clin Infect Dis 2005; 41:1569-75.
26. Griffith DE, Browne-Elliot BA, Shepperd S, McLarty J, Griffith L, Wallace RJ Jr. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2005; 172:250-3.
27. Griffith DE. Risk-benefit assessment of therapies for Mycobacterium avium complex infections. Drug Saf 1999; 21:137-52.
28. Shafran SD, Talbot JA, Chomyc S, et al. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. Clin Infect Dis 1998; 27:1401-5.